Back to Search
Start Over
Author Correction: Regorafenib is suitable for advanced colorectal cancer patients who have previously received trifluridine/tipiracil plus bevacizumab.
- Source :
-
Scientific reports [Sci Rep] 2023 Jul 24; Vol. 13 (1), pp. 11935. Date of Electronic Publication: 2023 Jul 24. - Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 2045-2322
- Volume :
- 13
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Scientific reports
- Accession number :
- 37488181
- Full Text :
- https://doi.org/10.1038/s41598-023-39009-5